Drug Class Monitoring
Drug Class Monitoring is a systematic pharmacovigilance framework that enables the ongoing evaluation of the safety, efficacy, and utilization patterns of a group of pharmacologically related therapeutic agents to inform clinical decision-making and regulatory policy.
9
Publications
298
Citations
29
Authors
15
Institutions
Publications per year
2017–2026
2
Variants
Therapeutic Class Monitoring
Parents
9
Antihypertensive persistence and drug class.
Michael Marentette, William C. Gerth, David K. Billings et al. · PubMed · 2002 · 127 citations
Drug Use in a Surgical Intensive Care Unit
Joseph F. Dasta · Drug Intelligence & Clinical Pharmacy · 1986 · 22 citations
Tysabri raises alarm bells on drug class
Cormac Sheridan · Nature Biotechnology · 2005 · 20 citations
1–5 of 9
29
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 29
15

Délégation Paris 5
Paris, France
1 h-index
3 publications
126 citations
Queen's University Belfast
Belfast, United Kingdom
1 h-index
1 publications
24 citations

Brigham and Women's Hospital
Boston, United States
1 h-index
6 publications
102 citations
Apple (Israel)
Herzliya, Israel
1 h-index
2 publications
84 citations
Oregon Health & Science University
Portland, United States
1 h-index
1 publications
10 citations
Université Paris Cité
Paris, France
1 h-index
3 publications
126 citations

Sorbonne Université
Paris, France
1 h-index
1 publications
42 citations
Merck Canada Inc. (Canada)
Kirkland, Canada
1 h-index
1 publications
127 citations
1–8 of 15
1 publications · 20 citations
1
h-index
1 publications · 42 citations
1
h-index
1 publications · 16 citations
1
h-index
1 publications · 17 citations
1
h-index
1 publications · 22 citations
1
h-index
1–5